Zenosis provide 'always up-to-date' e-learning and knowledge support for Regulatory and Compliance professionals working within the global Life Science industry.

Monoclonal antibody (mAb) use has advanced exponentially in the last 30 years. MAbs have evolved from being basic research tools, to diagnostic agents and more recently, to therapeutic agents.

Our latest release, 'Registration of Monoclonal Antibodies', identifies the studies and developmental aspects of mAbs vital to manufacturing safe and effective mAb products. This module also describes the regulatory requirements and pathways to license mAb products in the EU and US.

For information on other courses please view our catalogue, where a 14 day free trial can also be arranged.

If you would like one of our sales team to contact you to explain how so many global pharmaceutical and biotech companies are bringing about a paradigm shift in the effectiveness of their regulatory and compliance training and performance support, please drop us a mail with a suggested time and date you would like us to call.